The first veterinary clinical trial begins for a European Animal Health company: examining a new palatable phosphate binder for cats with chronic kidney disease. This trial has been approved by the University of Canberra Animal Ethics committee and will be run at A class veterinary practices within the ACT Veterinary Clinical Research network.




